News-Papers
Testimonial
Video Gallery
Search
Follow us...
Latest
- Membrane-bound melatonin receptor MT1 down-regulates estrogen responsive genes in breast cancer cells
- Expression of growth hormone receptor, plakoglobin and NEDD9 protein in association with tumour progression and metastasis in human breast cancer
- Melatonin as a potential inhibitory agent in head and neck cancer
- Co-expression of GH and GHR isoforms in prostate cancer cell lines
- Melatonin modulation of crosstalk among malignant epithelial, endothelial and adipose cells in breast cancer (Review)
- Effect of melatonin on the cytotoxicity of chemotherapeutic drugs in human leukemia cells
- Vitamin D deficiency
- Antiestrogens modulate MT1 melatonin receptor expression in breast and ovarian cancer cell lines
- Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety
- Radioprotective effect of melatonin on radiation-induced lung injury and lipid peroxidation in rats
- Molecular aspects of melatonin (MLT)-mediated therapeutic effects
- Breast Cancer and Prolactin - New Mechanisms and Models
- Melatonin as an anti-inflammatory agent in radiotherapy
- Somatostatin Radioligand Therapy of Breast Cancer: A Target of Opportunity
- Interactions of melatonin with various signaling pathways: implications for cancer therapy
- Efficacy of metronomic chemotherapy with oral cyclophosphamide and methotrexate in patients with non-hodgkin lymphoma: A retrospective analysis at a single institution
- Melatonin and vitamin D as potential synergistic adjuvants for cancer therapy (Review)
- Hybrid Somatostatin Receptor PET/MRI of the Head and Neck
Most Read
- The Di Bella Method (DBM)
- About melatonin - 1996
- All-trans-retinoic acid and cancer
- Biography
- Chronic Lymphocytic Leukemia: 4 patients, long-lasting remission
- Somatostatin in oncology, the overlooked evidences
- The Di Bella Method Increases by the 30% the survival rate for Pancreas tumors and for this reason should be proposed as first line therapy for this type of cancer
- Treatment of Low-grade Non-Hodgkin’s Lymphomas at Advanced Stage
- Complete objective response to biological therapy of plurifocal breast carcinoma
- How effective is chemo therapy?
- Bibliography
- Large B-cells Non-Hodgkin's Lymphoma, Stage IV-AE: a Case Report
- Vademecum
- Non-Hodgkin's Lymphoma, Stage III-B-E: a Case Report
- Frequently Asked Questions
- Declaration recommends eliminate the use of Impact factor for research evaluation
- Non–Small-Cell Lung Cancer Patients with Low Performance Status: study on 28 patients
- Breast cancer: study on 122 cases. The Di Bella Method (DBM) improved survival, objective response and performance status in a retrospective observational clinical study on 122 cases of breast cancer